Kanoria Chemicals & Industries Ltd

Kanoria Chemicals & Industries Ltd is rated 'Strong Sell' by MarketsMOJO. This rating was last updated on 16 December 2024, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 14 January 2026, providing investors with the latest perspective on the company’s performance and prospects.

Kanoria Chemicals & Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 December 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Kanoria Chem., a microcap player in the commodity chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, highlighting ongoing challenges in its operational and market performance.

Kanoria Chemicals & Industries has reached a new 52-week low of Rs.69.25, marking a significant decline in its stock price amid broader market movements and company-specific factors. The stock’s recent performance reflects ongoing pressures within the commodity chemicals sector and highlights challenges faced by the company over the past year.

Kanoria Chemicals & Industries touched a fresh 52-week low of Rs.70.06 today, marking a significant decline in its share price amid broader market pressures and sectoral headwinds. The stock’s performance continues to lag behind key benchmarks, reflecting ongoing concerns about its financial metrics and market positioning.

Kanoria Chemicals & Industries touched a fresh 52-week low of Rs.70.06 today, marking a significant decline amid a volatile trading session. The stock’s performance continues to trail behind its sector and benchmark indices, reflecting ongoing pressures within the commodity chemicals space.

Kanoria Chem., a microcap player in the Commodity Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a cautious stance for investors amid ongoing sector volatility.

Kanoria Chemicals & Industries has reached a new 52-week low, reflecting a significant decline in its performance this year. The stock has consistently underperformed against benchmark indices and is trading below key moving averages. Concerns are heightened by its high debt-to-EBITDA ratio and a substantial portion of pledged promoter shares.

Kanoria Chemicals & Industries has reached a new 52-week low, reflecting a significant decline over the past year. The company has consistently underperformed its sector and benchmark indices, with concerning financial metrics, including a low Return on Capital Employed and a high Debt to EBITDA ratio.

Kanoria Chemicals & Industries has hit a new 52-week low, reflecting a notable decline over the past year. The company's stock continues to underperform its sector and is trading below key moving averages. Broader market sentiment remains cautious amid challenges such as high debt levels and pledged promoter shares.

Kanoria Chemicals & Industries has reported strong financial metrics for the quarter ending September 2025, including a record cash position and a low debt-equity ratio. However, challenges remain with declining net sales and negative profit before tax. The company has shown resilience over five years, outperforming the Sensex.

Kanoria Chemicals & Industries Ltd. (NSE: KANORICHEM), a Kolkata-based commodity chemicals manufacturer with a market capitalisation of ₹336.00 crores, reported consolidated net profit of ₹93.44 crores for Q2 FY26, an extraordinary surge from a loss of ₹13.91 crores in the corresponding quarter last year. However, beneath this headline figure lies a troubling operational reality: standalone net loss of ₹2.24 crores, deteriorating operating margins, and mounting debt burdens that continue to weigh on the micro-cap company's prospects.